Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.165 AUD | +1.30% | +2.19% | -20.75% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.75% | 432M | - | ||
+16.50% | 62.48B | A- | ||
+0.46% | 20.2B | A- | ||
+7.31% | 8.11B | B | ||
-5.80% | 6.14B | B- | ||
+16.93% | 3.78B | C- | ||
+2.42% | 3.38B | C+ | ||
+12.32% | 3.31B | C | ||
-5.34% | 3.11B | B+ | ||
+19.96% | 2.91B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HCW Stock
- Ratings HealthCo Healthcare and Wellness REIT